Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 2/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.30 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.30 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11445424 | 1.00 | JAK3 (0.38) | JAK3MCL1PTPN1DDB1CRBN | |
| SCHEMBL11342695 | 0.73 | JAK3 (0.38) | JAK3PIM1PIM3ALKBH5FTO | |
| SCHEMBL30690427 | 0.73 | JAK3 (0.38) | JAK3PIM1PIM3ALKBH5FTO | |
| SCHEMBL10835548 | 0.69 | MCL1 (0.35) | MCL1PTPN1NLRP3ALKBH5FTO | |
| SCHEMBL31069844 | 0.69 | MCL1 (0.35) | MCL1PTPN1NLRP3ALKBH5FTO | |
| SCHEMBL11224645 | 0.68 | MCL1 (0.34) | MCL1PTPN1NLRP3 | |
| SCHEMBL31742533 | 0.66 | PIM1 (0.41) | JAK3MCL1PTPN1DDB1CRBN | |
| SCHEMBL7670850 | 0.64 | PTPN1 (0.41) | JAK3MCL1PTPN1DDB1CRBN | |
| SCHEMBL22955422 | 0.64 | KDM4E (0.48) | JAK3MCL1 | |
| SCHEMBL12165652 | 0.62 | NLRP3 (0.49) | MCL1PTPN1NLRP3ALKBH5FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026093905-A1 | NEW SELECTIVE ERAP INHIBITOR CANTHIN-6-ONE AND USES THEREOF | UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) | 2026-05-07 | — | — | WO | disclosed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | disclosed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | disclosed |
| EP-4229059-A1 | 3-SUBSTITUTED XANTHINE DERIVATIVES AS MRGPRX4 RECEPTOR MODULATORS | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2023-08-23 | — | — | EP | disclosed |
| CN-116582633-A | Method and apparatus for providing video content of multiple view point perspectives | 元平台公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-115894507-A | Method for synthesizing (+) -canna oensis alkali and application thereof | 昆明医科大学 | 2023-04-04 | — | — | CN | disclosed |
| EP-4132929-A2 | NOVEL NATURE-INSPIRED ANTICANCER AND ANTIBACTERIAL MOTIFS AND PHARMACEUTICAL COMPOSITION THEREOF | University of Sharjah (AE) | 2023-02-15 | — | — | EP | disclosed |
| CN-115397480-A | Flowable fibrinogen thrombin paste | 广州倍绣生物技术有限公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-113230254-B | Medicine for resisting SARS-CoV-2 and its application | 广州市朝利良生物科技有限公司 | 2022-08-23 | — | — | CN | disclosed |
| WO-2022079245-A1 | 3-SUBSTITUTED XANTHINE DERIVATIVES AS MRGPRX4 RECEPTOR MODULATORS | RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) | 2022-04-21 | — | — | WO | disclosed |